DISCONTOOLS Deliverables and Milestones Deliverabl e n

1 2 3 4

Deliverable name
Creation of appropriate working/expert groups as necessary to deal with specialised topics Fully functioning governance structure in place Early meeting of the governing bodies A well organised project with full stakeholder involvement through an initial stakeholder forum meeting Communication strategy developed, published and operational Established initial working/expert groups Project Web site established and maintained for duration of project Preliminary publications Production of an agreed list of criteria on which to base prioritisation Disease database for prioritisation and gap analysis in operation

Working Delivery date Delivered Package (proj. month) in

1 1 1 1 1 -24 as required 3 3 3-6

Comments

Milestone n
1

Milestone name
Governance established Meeting of advisory group

Working Delivery Date Delivered Package (proj. month) in

1, 5 1 3 6

Comments
Governing body appointed Meeting held

5 6 7 8 9 10

5 1 5 5 2 2

6 and ongoing 6 6 6 and then as appropriate 9 12

1st meeting of expert group on prioritisation 1st meeting of expert group on gap analysis Web site activated

2 3 5

9 9 6

Minutes of meeting Minutes of meeting Access to web site

1st meeting expert group on technology evaluation Preliminary database for disease information available Annual meeting of advisory group

4 1, 2, 3, 5 1 1 1

12 12 12 6 12

Minutes of meeting Database available Minutes of meeting Meeting held Report

11 12

First stakeholder meeting First annual report

5 1

12 12 12 and as sections of the project are completed 15 15 18 24

Initial meeting of stakeholders Annual review and progress report

13

Final publications Publish review of current methodologies for identifying new technologies Publish review of existing methodologies for prioritisation published Validated methodology for gap analysis available Standardised validated working model for prioritisation which is accepted by funders Answers to specific questions about tools for disease control: What is currently available for effective controls and is it fit for purpose?; What new tools are needed?; Is the research near to a breakthrough and does it have the potential to deliver the products?; What are the costs and timescales for delivery of the new tools? Standardised validated methodology for identification and evaluation of technological innovation Rapid identification of new technology and techniques as they are identified or published Assessment and evaluation of new technologies Use of new tecnhologies where appropriate to assist the development of diagnostics, pharmaceuticals and vaccines Second annual report Publication of list of peer reviewed prioritised major diseases Comprehensive analysis for each of the priority diseases available, identifyibg the gaps in knowledge and availability of control tools Publication of prioritisation model

14 15 16 17

4 2 3 2

Review of prioritisation methodologies published Validated methodology for gap analysis Annual meeting of advisory group

2 3 1

12 18 24

Published review In use and publicised Minutes of meeting

18

24

19 20 21 22 23 24 25 26

4 4 4 4 1 2 3 2

24 24 - 48 24 - 36 24 - 48 24 30 36 36

Validated methodology for technology evaluation

18

In use and publicised

Assessment of new technologies

24

On going publications

Annual review and progress report List of prioritised disease Annual meeting of advisory group Publication of prioritisation model

1 2 1 2

24 24 36 30

Report Publication Minutes of meeting Publication

27 28 29 30 31 32

Use of methodology to evaluate new technologies in relation to priority diseases Third annual report Interactive web site for access to prioritisation model and gap analysis Comprehensive database with web access for each of the priority diseases Regular communications with all stakeholders and final stakeholder conference Management of the project until completion Final scientific reports: On research requirements to fill the gaps and encourage the development of new or improved tools for each of the priority diseases; Of a standardised validated methodology to determine gaps and research priorities with more accuracy. Final report on the methodology Final Report and accounts

4 1 5 2 5 1

36 36 42 42 48 48 Web access to models and databases 2, 3, 4, 5 36 Access Annual review and progress report 1 36 Report

33

1, 3

48

Final scientific, technical report

1, 5

48

Report

34 35

4 1

48 48 Final administrative and financial report 1, 5 48 Report